Fed Regist. 2016 Feb 5;81(24):6171-5.
The Administrator of the Drug Enforcement Administration is issuing this final order to temporarily schedule the synthetic cannabinoid N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (common names, MAB-CHMINACA and ADB-CHMINACA), and its optical, positional, and geometric isomers, salts, and salts of isomers into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act. This action is based on a finding by the Administrator that the placement of this synthetic cannabinoid into schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, MAB-CHMINACA.
美国缉毒局局长发布本最终命令,根据《受控物质法》的临时管制规定,暂时将合成大麻素N-(1-氨基-3,3-二甲基-1-氧代丁烷-2-基)-1-(环己基甲基)-1H-吲唑-3-甲酰胺(通用名称,MAB-CHMINACA和ADB-CHMINACA)及其光学、位置和几何异构体、盐类以及异构体的盐类列入附表一。此行动基于局长的一项认定,即将这种合成大麻素列入《受控物质法》附表一是避免对公众安全造成紧迫危害所必需的。由于本命令,适用于附表一受控物质的监管控制措施以及行政、民事和刑事制裁将施加于处理(制造、分销、反向分销、进口、出口、从事研究、开展教学活动或化学分析,或持有)或提议处理MAB-CHMINACA的人员。